TY  - JOUR
AU  - Reolid, Alejandra
AU  - Armesto, Susana
AU  - Sahuquillo-Torralba, Antonio
AU  - Torres, Tiago
AU  - Feltes, Rosa
AU  - Vilarrasa, Eva
AU  - Belinchón, Isabel
AU  - Cueva, Pablo de la
AU  - Rodríguez, Lourdes
AU  - Romero-Maté, Alberto
AU  - Vidal, David
AU  - Coto-Segura, Pablo
AU  - Herrera-Acosta, Enrique
AU  - Riera-Monroig, Josep
AU  - Salgado, Laura
AU  - Llamas-Velasco, Mar
AU  - Daudén, Esteban
PY  - 2022
DO  - 10.1016/j.jaad.2022.05.047
UR  - http://hdl.handle.net/10668/22281
T2  - Journal of the American Academy of Dermatology
LA  - en
KW  - daily practice setting
KW  - palmoplantar psoriasis
KW  - palmoplantar pustular psoriasis
KW  - secukinumab
KW  - Antibodies, Monoclonal, Humanized
KW  - Humans
KW  - Psoriasis
TI  - Secukinumab is effective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting.
TY  - research article
VL  - 87
ER  -